Statistics for Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential
Total visits
views | |
---|---|
Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential | 260 |
Total visits per month
views | |
---|---|
January 2024 | 0 |
February 2024 | 0 |
March 2024 | 0 |
April 2024 | 0 |
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
File Visits
views | |
---|---|
10.pdf | 289 |
Top country views
views | |
---|---|
United States | 199 |
Germany | 11 |
Sweden | 9 |
Ukraine | 6 |
Canada | 3 |
Russia | 3 |
China | 2 |
United Kingdom | 1 |
Lebanon | 1 |
Malaysia | 1 |
Netherlands | 1 |
Top city views
views | |
---|---|
Wilmington | 53 |
Fairfield | 23 |
Ann Arbor | 15 |
Houston | 15 |
Kiez | 9 |
Stockholm | 8 |
Cambridge | 7 |
Jacksonville | 7 |
White Plains | 7 |
Kiev | 6 |
San Francisco | 4 |
Saint Petersburg | 3 |
Toronto | 3 |
Beijing | 2 |
Brooklyn | 2 |
Chicago | 2 |
Concord | 2 |
Gunzenhausen | 2 |
Kansas City | 2 |
Washington | 2 |
Baltimore | 1 |
Beirut | 1 |
Brookline | 1 |
Champaign | 1 |
Den Haag | 1 |
Indianapolis | 1 |
Lake Mary | 1 |
Motala | 1 |
Overland Park | 1 |
Philadelphia | 1 |
Scottsdale | 1 |
Seremban | 1 |